Hazlett, Burt & Watson’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Hazlett, Burt & Watson's WST Position: Q3 2026 in Review
Hazlett, Burt & Watson held its West Pharmaceutical (WST) position steady in Q3 2026 at 100 shares worth $37K. The position accounts for 0.01% of the portfolio, ranked #518.
Hazlett, Burt & Watson first reported a position in WST in Q1 2024 and has held it in 11 quarters since. The position peaked at $40K in Q1 2024. 875 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Hazlett, Burt & Watson held 100 shares of West Pharmaceutical worth $37K as of Q3 2026.
- Hazlett, Burt & Watson left its West Pharmaceutical share count unchanged in Q3 2026.
- West Pharmaceutical made up 0.01% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #518 holding.
- Hazlett, Burt & Watson first reported a position in West Pharmaceutical in Q1 2024 and has held it in 11 quarters since.
- Hazlett, Burt & Watson's West Pharmaceutical position peaked at $40K in Q1 2024.
- 875 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.